Navigation Links
Antiviral Drugs Market to Reach US$82.9 Bn by 2024: Rising Prevalence of HIV/AIDS and Hepatitis to Boost Market's Growth, Finds TMR
Date:3/8/2017

ALBANY, New York, March 8, 2017 /PRNewswire/ --

With Gilead Sciences holding a share of 51% in 2015, the global antiviral market emerged highly consolidated in 2015 and the scenario is likely to be more or less the same over the next few years, states a report by Transparency Market Research (TMR). Although the competition within this market moderate as of now, the increasing entry of new companies may intensify it in the near future. 

As per the report's estimations, the global antiviral drugs market offered an opportunity worth US$48.3 bn in 2015. Anticipated to rise at a CAGR of 6.40% during the period from 2016 to 2024, the market will reach US$82.9 bn by the end of the forecast period. Currently, the demand for antiviral drugs from the HIV infection segment is higher than others and is expected to remain so over the next few years due to the alarming increase in the cases of HIV infection. 

Browse Market Research Report @ http://www.transparencymarketresearch.com/antiviral-drugs-market.html

Escalating Patient Pool to Ensure North America's Position as Leading Consumer of Antiviral Drugs 

The report considers Asia pacific, North America, Latin America, the Middle East and Africa, and Europe as the prime regional markets for antiviral drugs and presents a comparative assessment of them in order to identify the leading and the most attractive ones. North America, amongst all, led the global market in 2015 with a share of more than 50%. Thanks to the expanding pool of patients suffering from viral infections, this regional market is likely to continue at this position throughout the period of the forecast. 

Europe, which acquired the second position in the global market in 2015, is anticipated to remain seated in this position over the next few years. The large pool of patients undertaking antiretroviral treatments, thanks to the rise in their preference for novel drugs, will surface as the key factor behind the growth of this regional in the years to come. Apart from this, the increasing level of awareness among consumers regarding the treatment of viral infections, technological advancements in diagnostic facilities, introduction of efficient drugs on a regular basis, and a favorable reimbursement scenario are also predicted to boost the Europe market for antiviral drugs in the near future. 

On the other hand, Asia Pacific, closely followed by the Middle East and Africa, is expected to offer lucrative growth opportunities to the producers of antiviral drugs in the coming years due to the unmet medical needs of people residing in this region. The significant rise in the prevalence of hepatitis and HIV/AIDS and the frequent outbreak of infectious viral diseases, such as influenza are likely to fuel the demand for antiviral drugs in this region over the next few years. Along with this, the rising demand for novel antiviral drugs and improved yet affordable second version treatments, owing to the recent outbreak of new viral infections, especially Ebola and Zika, is projected add significantly to both the markets, i.e., Asia Pacific and the Middle East and Africa, over the forecast period, states the report. 

Fill the form for an exclusive sample of this report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21083

Increasing Incidence of Viral Infections to Drive Demand for Antiviral Drugs 

"The global market for antiviral drugs is deriving much of its growth from the increasing incidence of viral infections across the world," states the author of this study. Currently, the world is facing a severe threat from the rising prevalence of chronic infections, such as HIV/AIDS and hepatitis B. The treatment of these diseases requires long-term therapies, leading to prolonged usage of antiviral drugs. This, as a result, is propelling this market substantially. 

Over the coming years, the increasing focus of drugmakers on the research activities for the innovation and advancements in antiviral drugs and therapies, boosted by the frequent reports of new viral infectious disease outbreaks, is expected to influence this market positively in the near future. However, the high capital investment needed for drug development may hamper the progress of this market to some extent over the forthcoming years, notes the study. 

Browse Press Release: http://www.transparencymarketresearch.com/pressrelease/antiviral-drugs-market.htm

The study presented here is based on a report by Transparency Market Research (TMR), titled "Antiviral Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2016 - 2024." 

The global antiviral drugs market is segmented as follows: 

By Disease Indication 

  • Hepatitis Virus Infection
  • HIV Infection
  • Respiratory Virus Infection
  • Others 

By Product Type 

  • Branded Drugs
  • Generic Drugs 

By Distribution Channels 

  • Hospital Pharmacy Store
  • Retail Pharmacy Store
  • Online Pharmacy 

By Geography 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Browse Related Research Report: 

Companion Diagnostics Market (Indication Type - Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, Thalassemia, and HIV) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

http://www.transparencymarketresearch.com/companion-diagnostics-market.html

Vaccine Market (Human Vaccines: Hepatitis, Influenza, Meningococcal, Pneumococcal, HPV, Combination Vaccines; Animal Vaccines: Canine, Feline, Porcine, Bovine, Ovine, Poultry and Equine) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

http://www.transparencymarketresearch.com/us-vaccine-market.html

Retail Clinics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

http://www.transparencymarketresearch.com/retail-clinics-market.html

About Us: 

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/


'/>"/>
SOURCE Transparency Market Research
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Antiviral Therapeutics Report - Technologies, Markets and Companies - 2013-2022
2. A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market
3. ContraVir Pharmaceuticals Selects Pharmaceutical Product Development to Manage Phase 2b Study of Lead Antiviral FV-100 for Treating Shingles
4. Global Antiviral Therapeutics Report 2015 - Technologies, Markets and Companies Forecasts to 2024
5. Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL
6. Global Antiviral Therapeutics Technologies, Markets and Companies Analysis Report 2015-2024
7. Kineta Presents Promising New Data on Novel Lassa Fever Antiviral and Broad Spectrum Innate Immune Antivirals
8. A Subsidiary of Rostec Corporation and HTC ChemRar Launch a Joint Venture for Development and Manufacturing of the Next Generation of Antivirals in Russia and the Eurasian Economic Union
9. Global Antiviral Therapeutics Technologies, Markets and Companies Report 2015-2025: Profiles of 194 Companies with 173 Collaborations - Research and Markets
10. China Nepstar Chain Drugstore Ltd. Announces Appointment of New Director
11. China Nepstar Chain Drugstore Ltd. Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Oct. 12, 2017 AVACEN Medical , Inc. ... with their  2017 New Product Innovation Award for Its ... primary and secondary medical device market research by Frost & ... first-to-market OTC, drug-free pain relief product, the AVACEN 100, offers ... treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
Breaking Medicine News(10 mins):